Sarepta Therapeutics, INC. (SRPT) — DEF 14A Filings

All DEF 14A filings from Sarepta Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Sarepta Therapeutics Files DEF 14A on Executive Compensation — Apr 24, 2025 Risk: low
Sarepta Therapeutics, Inc. filed a DEF 14A on April 24, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending Decem
Sarepta Therapeutics, Inc. Files Definitive Proxy Statement (DEF 14A) — Apr 24, 2024 Risk: low
Sarepta Therapeutics, Inc. (SRPT) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. Sarepta Therapeutics, Inc. filed a Definitive Proxy Statemen

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX